Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 56 min 52 sec ago

Boston Scientific Announces Definitive Agreement To Acquire American Medical Systems' Urology Portfolio For Up To $1.65 Billion

Mon, 03/02/2015 - 15:33
Combined Business to Advance Patient Care with Leading Solutions Across Major Urology Categories MARLBOROUGH, Mass., March 2, 2015 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) today announced that it has entered into...
Devices, Urology, Mergers & Acquisitions
Boston Scientific, Endo International, American Medical Systems

Mersana Raises $35 Million in Series B Financing and Appoints Anna Protopapas as President and Chief Executive Officer

Mon, 03/02/2015 - 15:28
Funding to advance its internal pipeline First Fleximer® antibody-drug conjugate IND to be filed in 2015 CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Mersana Therapeutics, Inc., announced today that it raised $35 million in Series B-...
Devices, Drug Delivery, Venture Capital, Personnel
Mersana Therapeutics, Fleximer, antibody-drug conjugate

Tryton Medical Announces Publication of Data from Pivotal Trial for Tryton Side Branch Stent in Journal of American College of Cardiology

Mon, 03/02/2015 - 13:43
Results from largest study in treatment of coronary bifurcations demonstrate reductions in TVF and side branch percent stenosis in intended population of patients with complex lesions involving significant side branches DURHAM, N.C.--(Healthcare Sales &...
Devices, Interventional Cardiology
Tryton Medical, Side Branch Stent, coronary bifurcation

Macrocure Hires Dr. Ramesh Tharuvai, Ph.D. as Vice President, Operations

Mon, 03/02/2015 - 13:37
PETACH TIKVA, Israel, March 2, 2015 -- (Healthcare Sales & Marketing Network) -- Macrocure Ltd. (MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds, today announce...
Biopharmaceuticals, Wound Care, Personnel

FDA Approves Allergan’s NATRELLE INSPIRA(TM) Round Gel-Filled Breast Implants

Fri, 02/27/2015 - 15:05
NATRELLE INSPIRA™ Represents Company’s Latest Innovation in Breast Implants Provides New Implant Option for Surgeons and Patients Seeking Reconstruction, Augmentation or Revision Surgery IRVINE, Calif.--(Healthcare Sales & Marketing Network)--Allerg...
Devices, FDA
Allergan, NATRELLE INSPIRA, breast implant

Chiasma Announces Completion of $70 Million Series E Financing

Fri, 02/27/2015 - 14:49
NEWTON, Mass. and JERUSALEM, Feb. 27, 2015 -- (Healthcare Sales & Marketing Network) -- Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closin...
Biopharmaceuticals, Venture Capital
Chiasma, octreotide capsules, acromegaly

Varian Medical Systems to Make Radiotherapy Available for More Cancer Patients in Africa

Fri, 02/27/2015 - 13:55
Varian presenting cancer treatment strategy to governments and healthcare leaders at Africa Healthcare Summit in London LONDON, Feb. 27, 2015 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (VAR), world leader in radiation therapy, ...
Devices, Oncology
Varian Medical Systems, radiotherapy

FDA Advisory Committee Recommends Approval for Avedro’s Riboflavin Ophthalmic Solutions with UVA Irradiation for Corneal Collagen Cross-Linking to Treat Progressive Keratoconus and Corneal Ectasia

Fri, 02/27/2015 - 13:45
WALTHAM, Mass.--(Healthcare Sales & Marketing Network)--Avedro, Inc., a Boston-based ophthalmic pharmaceutical and medical device company, announced today that on February 24, 2015 the U.S. Food and Drug Administration (FDA) Dermatologic and Ophthalmic Dru...
Biopharmaceuticals, Ophthalmology, FDA
Avedro, corneal ectasia, riboflavin ophthalmic, KXL System

EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Retinal Vein Occlusion

Thu, 02/26/2015 - 18:02
TARRYTOWN, N.Y., Feb. 26, 2015 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual imp...
Biopharmaceuticals, Ophthalmology, Regulatory
Regeneron Pharmaceuticals, EYLEA, aflibercept, Macular Edema

Boston Scientific Launches Next Generation SpyGlass(TM) DS Direct Visualization System For Advanced Diagnosis And Treatment Of Pancreatico-biliary Diseases

Thu, 02/26/2015 - 17:59
MARLBOROUGH, Mass., Feb. 26, 2015 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) announces 510(k) clearance and the first cases of the SpyGlass DS Direct Visualization System used for cholangioscopy and pancreatoscopy pro...
Devices, Interventional, Product Launch
Boston Scientific, SpyGlass, cholangioscopy, pancreatoscopy

Meridian Bioscience Receives CE Marking for Two New Molecular Amplification Tests: illumigene(R) Chlamydia and illumigene(R) Gonorrhea

Thu, 02/26/2015 - 17:55
CINCINNATI--(Healthcare Sales & Marketing Network)--Meridian Bioscience, Inc., Cincinnati, Ohio (VIVO) today announced that it has received the CE Mark for two new molecular diagnostic tests for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), th...
Diagnostics, Regulatory
Meridian Bioscience, illumigene, Chlamydia, Gonorrhea

EDAP Expands Product Portfolio With New Urological Stone Lasers

Thu, 02/26/2015 - 17:53
LYON, France, Feb. 26, 2015 -- (Healthcare Sales & Marketing Network) -- EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, today announced a multi-national strategic OEM partnership with Quanta System, a leading manufacturer of medical laser...
Devices, Urology
EDAP TMS, urological stone, lithotripsy

Topline Results of Phase 3 Trial Show Eribulin Mesylate Injection Meets Primary Endpoint of Overall Survival in Advanced Soft Tissue Sarcoma

Wed, 02/25/2015 - 13:53
Eisai Demonstrates Commitment to Patients with Rare Cancers WOODCLIFF LAKE, N.J., Feb. 25, 2015 -- (Healthcare Sales & Marketing Network) -- Eisai Inc. today announced that eribulin met the primary endpoint in its Phase 3 trial (Study 309), demonstrati...
Biopharmaceuticals, Oncology
Eisai, sarcoma, eribulin, Halaven

Ampio Announces Top-Line Results of the Double-Blind Multiple Intra-Articular Injections (STRUT) Study of Ampion(TM) in Patients with Moderate to Severe Osteoarthritis of the Knee

Wed, 02/25/2015 - 13:43
ENGLEWOOD, Colo., Feb. 25, 2015 -- (Healthcare Sales & Marketing Network) -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced results of the double-blind, multiple injection, vehicle controlled STRUT study (N=40) at 20 weeks. The forty pati...
Biopharmaceuticals, Orthopaedic
Ampio Pharmaceuticals, Ampion, osteoarthritis

Sunshine Heart Receives FDA Approval for Interim Analysis of U.S. Pivotal Trial of C-Pulse(R) Heart Assist System

Wed, 02/25/2015 - 13:33
EDEN PRAIRIE, Minn., Feb. 25, 2015 -- (Healthcare Sales & Marketing Network) -- Sunshine Heart, Inc. (SSH) today announced it has received unconditional approval from the FDA to conduct an interim analysis of COUNTER HF, the Company's U.S. pivotal study. T...
Devices, Cardiology, FDA
Sunshine Heart, COUNTER HF, C-Pulse system, balloon counterpulsation

Uroplasty Announces Positive Coverage Decision For Percutaneous Tibial Nerve Stimulation By Cigna

Tue, 02/24/2015 - 18:15
MINNEAPOLIS, Feb. 24, 2015 -- (Healthcare Sales & Marketing Network) -- Uroplasty, Inc. (UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that Cigna has w...
Devices, Urology, Reimbursement
Uroplasty, Percutaneous Tibial Nerve Stimulation, Urgent PC, Neuromodulation

Shire Acquires Meritage Pharma

Tue, 02/24/2015 - 13:36
Transaction Adds Phase 3-Ready Rare GI Disease Product to Strong Pipeline LEXINGTON, Massachusetts and SAN DIEGO, February 24, 2015 -- (Healthcare Sales & Marketing Network) --Shire plc (LSE: SHP, NASDAQ: SHPG) and Meritage Pharma, Inc. announced today...
Biopharmaceuticals, Mergers & Acquisitions
Shire plc, Meritage Pharma

ETView Reports on Clinical Evaluation of VivaSight(TM)

Tue, 02/24/2015 - 13:28
University Hospital Zurich, (Zurich, Switzerland) Evaluated VivaSight™ in 40 Patients Undergoing One Lung Ventilation. Results Demonstrate Elimination of Flexible Fiberoptic Bronchoscopy, and Reduction in Procedure Time TEL AVIV, Israel--(Healthcare Sal...
ETView Medical, VivaSight, endotracheal tubes, bronchoscopy

Nakashima and Teijin to Establish Joint Venture for Global Expansion of Japanese-made Medical Device Business

Mon, 02/23/2015 - 14:07
Tokyo, Japan, February 23, 2015 -(Healthcare Sales & Marketing Network)- Nakashima Holdings Co., Ltd. and Teijin Limited announced today that Teijin will acquire, through a third-party allotment, new shares of Nakashima Medical Co., Ltd., Nakashima Holding...
Devices, Orthopaedic, Mergers & Acquisitions
Teijin, Nakashima

Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in Primary Liver Cancer

Mon, 02/23/2015 - 13:45
Analysis of 285 Patient Subgroup Shows an Impressive Statistically Significant 59% Improvement in Overall Survival Results at Two Years Post Treatment Continue to Support Protocol for Ongoing Phase III OPTIMA Trial LAWRENCEVILLE, N.J., Feb. 23, 2015 ...
Biopharmaceuticals, Oncology
Celsion, ThermoDox, doxorubicin, liver cancer

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong